15-17 April, 2019

The Waldorf Hilton

London, UK

Personal Genome Diagnostics

personal-genome-diagnostics-1

Personal Genome Diagnostics: Programme Partner

Personal Genome Diagnostics (PGDx) advances the frontiers of cancer medicine through innovative genomic technologies for oncology researchers, drug developers, clinicians and patients. The expert team at PGDx draws on a deep understanding of cancer biology, extensive experience in cancer genomics and clinical oncology, and the company’s distinctive technologies.

These novel technologies precisely identify and characterize unique genomic alterations in tumors. PGDx is working toward broad patient access to its genomic approaches, through a CLIA-certified facility providing comprehensive genomic services, PROGENEUS™ technology transfer solutions and in-vitro diagnostic products enabling other molecular laboratories to easily internalize testing. For additional information, visit www.personalgenome.com.